patent/CN-107090476-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107090476-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a80b7a20e90688a32939a46274302cc
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
classificationIPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
filingDate	2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a45530d497dec21d2331e423c0320f9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daa05403b21be0c6a7d020d50be0311d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e04c3a49b40cf576d7e044aa53906ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb44877dfc25ec4ebfed9a18ce7c7a46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4257cb24eaa320128cc3b2fb813bbe
publicationDate	2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-107090476-A
titleOfInvention	Sanglifehrin derivatives and preparation methods thereof
abstract	The present invention relates to Sanglifehrin derivatives and their preparation methods, especially provides compounds of formula (I) and (II), and their use in therapy, especially for the treatment of viral infections.
priorityDate	2010-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9702285-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6124453-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465199299 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465963217 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163591145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164116641

Total number of triples: 35.